These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 31181961)

  • 21. The impact of antiretroviral therapy and isoniazid preventive therapy on tuberculosis incidence in HIV-infected patients in Rio de Janeiro, Brazil.
    Golub JE; Saraceni V; Cavalcante SC; Pacheco AG; Moulton LH; King BS; Efron A; Moore RD; Chaisson RE; Durovni B
    AIDS; 2007 Jul; 21(11):1441-8. PubMed ID: 17589190
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Completion of isoniazid preventive therapy for latent tuberculosis infection among children and adolescents compared to adults living with HIV in Kinshasa, Democratic Republic of the Congo.
    Bidashimwa D; Ditekemena JD; Sigwadhi LN; Nkuta LM; Engetele E; Kilundu A; Chabikuli ON; Nachega JB
    Trop Med Int Health; 2024 Feb; 29(2):88-95. PubMed ID: 38123460
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Isoniazid preventive therapy use among adult people living with HIV in Zimbabwe.
    Takamiya M; Takarinda K; Balachandra S; Godfrey M; Radin E; Hakim A; Pearson ML; Choto R; Sandy C; Maphosa T; Rogers JH
    Int J STD AIDS; 2021 Oct; 32(11):1020-1027. PubMed ID: 33978529
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The effect of partner HIV status on motivation to take antiretroviral and isoniazid preventive therapies: a conjoint analysis.
    Kim HY; Hanrahan CF; Dowdy DW; Martinson N; Golub J; Bridges JFP
    AIDS Care; 2018 Oct; 30(10):1298-1305. PubMed ID: 29595060
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Implementation and Operational Research: Feasibility of Using Tuberculin Skin Test Screening for Initiation of 36-Month Isoniazid Preventive Therapy in HIV-Infected Patients in Resource-Constrained Settings.
    Huerga H; Mueller Y; Ferlazzo G; Mpala Q; Bevilacqua P; Vasquez B; Noël Mekiedje C; Ouattara A; Mchunu G; Weyenga HO; Varaine F; Bonnet M
    J Acquir Immune Defic Syndr; 2016 Apr; 71(4):e89-95. PubMed ID: 26910386
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Isoniazid preventive therapy: Uptake, incidence of tuberculosis and survival among people living with HIV in Bulawayo, Zimbabwe.
    Nyathi S; Dlodlo RA; Satyanarayana S; Takarinda KC; Tweya H; Hove S; Matambo R; Mandewo W; Nyathi K; Sibanda E; Harries AD
    PLoS One; 2019; 14(10):e0223076. PubMed ID: 31581271
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Brief Report: High Programmatic Isoniazid Preventive Therapy (IPT) Use in Pregnancy Among HIV-Infected Women.
    LaCourse SM; Wagner AD; Cranmer LM; Copeland A; Maleche-Obimbo E; Richardson BA; Matemo D; Kinuthia J; John-Stewart G
    J Acquir Immune Defic Syndr; 2019 Sep; 82(1):41-45. PubMed ID: 31408031
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Drop-offs in the isoniazid preventive therapy cascade among children living with HIV in western Kenya, 2015-2019.
    Onyango DO; van der Sande MAB; Yuen CM; Mecha J; Matemo D; Oele E; Kinuthia J; John-Stewart G; LaCourse SM
    J Int AIDS Soc; 2022 Aug; 25(8):e25939. PubMed ID: 35927793
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Isoniazid Preventive Therapy Completion in the Era of Differentiated HIV Care.
    Tram KH; Mwangwa F; Atukunda M; Owaraganise A; Ayieko J; Plenty A; Kwariisima D; Clark TD; Petersen ML; Charlebois ED; Kamya MR; Chamie G; Havlir DV; Marquez C;
    J Acquir Immune Defic Syndr; 2017 Dec; 76(5):e115-e117. PubMed ID: 28885271
    [No Abstract]   [Full Text] [Related]  

  • 30. Completion of isoniazid preventive therapy among HIV-infected patients in Tanzania.
    Munseri PJ; Talbot EA; Mtei L; Fordham von Reyn C
    Int J Tuberc Lung Dis; 2008 Sep; 12(9):1037-41. PubMed ID: 18713501
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Factors affecting uptake and completion of isoniazid preventive therapy among HIV-infected children at a national referral hospital, Kenya: a mixed quantitative and qualitative study.
    Ngugi SK; Muiruri P; Odero T; Gachuno O
    BMC Infect Dis; 2020 Apr; 20(1):294. PubMed ID: 32664847
    [TBL] [Abstract][Full Text] [Related]  

  • 32. To start or to complete? - Challenges in implementing tuberculosis preventive therapy among people living with HIV: a mixed-methods study from Karnataka, India.
    Reddy MM; Thekkur P; Ramya N; Kamath PBT; Shastri SG; Kumar RBN; Chinnakali P; Nirgude AS; Rangaraju C; Somashekar N; Kumar AMV
    Glob Health Action; 2020; 13(1):1704540. PubMed ID: 31937200
    [No Abstract]   [Full Text] [Related]  

  • 33. Use of isoniazid preventive therapy for tuberculosis prophylaxis among people living with HIV/AIDS: a review of the literature.
    Briggs MA; Emerson C; Modi S; Taylor NK; Date A
    J Acquir Immune Defic Syndr; 2015 Apr; 68 Suppl 3(Suppl 3):S297-305. PubMed ID: 25768869
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Acceptability of treatment of latent tuberculosis infection in newly HIV-infected young women in Uganda.
    Bark CM; Morrison CS; Salata RA; Byamugisha JK; Katalemwa NH; Mugerwa RD; Mukasa JB; Musoke RN; Nankya-Mutyoba J; Rwambuya S; Walker CJ; Johnson JL
    Int J Tuberc Lung Dis; 2010 Dec; 14(12):1647-9. PubMed ID: 21144254
    [TBL] [Abstract][Full Text] [Related]  

  • 35. CD4+ cell count stratification to guide tuberculosis preventive therapy for people living with HIV.
    Chaisson LH; Saraceni V; Cohn S; Seabrook D; Cavalcante SC; Chaisson RE; Golub JE; Durovni B
    AIDS; 2020 Jan; 34(1):139-147. PubMed ID: 31634189
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Completion of isoniazid preventive therapy and survival in HIV-infected, TST-positive adults in Tanzania.
    Kabali C; von Reyn CF; Brooks DR; Waddell R; Mtei L; Bakari M; Matee M; Pallangyo K; Arbeit RD; Horsburgh CR
    Int J Tuberc Lung Dis; 2011 Nov; 15(11):1515-21, i. PubMed ID: 22008766
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Household point of care CD4 testing and isoniazid preventive therapy initiation in a household TB contact tracing programme in two districts of South Africa.
    Page-Shipp L; Lewis JJ; Velen K; Senoge S; Zishiri E; Popane F; Chihota VN; Clark D; Churchyard GJ; Charalambous S
    PLoS One; 2018; 13(3):e0192089. PubMed ID: 29499060
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Isoniazid preventive therapy and 4-year incidence of pulmonary tuberculosis among HIV-infected Thai patients.
    Khawcharoenporn T; Apisarnthanarak A; Manosuthi W; Sungkanuparph S; Mundy LM
    Int J Tuberc Lung Dis; 2012; 16(3):336-41. PubMed ID: 22230143
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The implementation of isoniazid preventive therapy in HIV clinics: the experience from the TB/HIV in Rio (THRio) study.
    Durovni B; Cavalcante SC; Saraceni V; Vellozo V; Israel G; King BS; Cohn S; Efron A; Pacheco AG; Moulton LH; Chaisson RE; Golub JE
    AIDS; 2010 Nov; 24 Suppl 5(Suppl 5):S49-56. PubMed ID: 21079428
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Survey of isoniazid preventive therapy in South Africa, 2011.
    Chehab JC; Vilakazi-Nhlapo K; Vranken P; Peters A; Klausner JD
    Int J Tuberc Lung Dis; 2012 Jul; 16(7):903-7. PubMed ID: 22583688
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.